Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development
- PMID: 16870003
- DOI: 10.1079/bjn20061789
Dietary supplementation of resveratrol suppresses colonic tumour incidence in 1,2-dimethylhydrazine-treated rats by modulating biotransforming enzymes and aberrant crypt foci development
Abstract
Diet-induced changes in the activities of bacterial enzymes are known to play a role in colon cancer development. Resveratrol has been implicated as a protective agent in carcinogenesis. In the present study, the effect of resveratrol on the activities of faecal and colonic biotransforming enzymes such as beta-glucuronidase, beta-glucosidase, beta-galactosidase, mucinase, nitroreductase and faecal sulfatase activity was assessed. The total number of aberrant crypt foci and their distribution in the proximal, medial and distal colon were observed in 1,2-dimethylhydrazine (DMH)-induced rats (group 3) and other treatment groups (groups 4-6). DMH (0.02 g/kg body weight) was given subcutaneously once a week for 15 consecutive weeks, and the experiment was terminated at 30 weeks. DMH-treated rats showed elevated levels of cancer-associated bacterial enzyme activities, whereas on resveratrol supplementation in three different regimens, rats showed lowered activities. Resveratrol supplementation throughout the experimental period (group 6) exerted a more pronounced effect (P < 0.01) by modulating the development of aberrant crypt foci and the activities of bacterial enzymes than did the other treatment regimens (groups 4 and 5). Thus, the present results demonstrate the inhibitory effect of resveratrol on DMH-induced colon carcinogenesis in rats.
Similar articles
-
Effect of hesperetin, a citrus flavonoid, on bacterial enzymes and carcinogen-induced aberrant crypt foci in colon cancer rats: a dose-dependent study.J Pharm Pharmacol. 2008 Oct;60(10):1385-92. doi: 10.1211/jpp/60.10.0015. J Pharm Pharmacol. 2008. PMID: 18812032
-
Modifying effects of morin on the development of aberrant crypt foci and bacterial enzymes in experimental colon cancer.Food Chem Toxicol. 2009 Feb;47(2):309-15. doi: 10.1016/j.fct.2008.11.017. Epub 2008 Nov 19. Food Chem Toxicol. 2009. PMID: 19056454
-
Dose dependent inhibitory effect of dietary caraway on 1,2-dimethylhydrazine induced colonic aberrant crypt foci and bacterial enzyme activity in rats.Invest New Drugs. 2006 Nov;24(6):479-88. doi: 10.1007/s10637-006-6801-0. Invest New Drugs. 2006. PMID: 16598436
-
Resveratrol in human cancer chemoprevention--choosing the 'right' dose.Mol Nutr Food Res. 2012 Jan;56(1):7-13. doi: 10.1002/mnfr.201100400. Epub 2011 Oct 7. Mol Nutr Food Res. 2012. PMID: 22218912 Review.
-
Short-term tests and long-term prospects for colon cancer prevention.Med Oncol Tumor Pharmacother. 1990;7(2-3):131-6. doi: 10.1007/BF02988540. Med Oncol Tumor Pharmacother. 1990. PMID: 2232932 Review.
Cited by
-
The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models.Cell Death Dis. 2014 Nov 20;5(11):e1533. doi: 10.1038/cddis.2014.486. Cell Death Dis. 2014. PMID: 25412311 Free PMC article.
-
Synergistic anticancer activity of resveratrol-loaded polymeric nanoparticles and sunitinib in colorectal cancer treatment.R Soc Open Sci. 2025 Apr 23;12(4):241817. doi: 10.1098/rsos.241817. eCollection 2025 Apr. R Soc Open Sci. 2025. PMID: 40271141 Free PMC article.
-
Gastrointestinal microflora, food components and colon cancer prevention.J Nutr Biochem. 2009 Oct;20(10):743-52. doi: 10.1016/j.jnutbio.2009.06.001. Epub 2009 Aug 27. J Nutr Biochem. 2009. PMID: 19716282 Free PMC article. Review.
-
High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.Diabetes. 2013 Apr;62(4):1186-95. doi: 10.2337/db12-0975. Epub 2012 Nov 28. Diabetes. 2013. PMID: 23193181 Free PMC article. Clinical Trial.
-
The Role of Resveratrol in Cancer Therapy.Int J Mol Sci. 2017 Dec 1;18(12):2589. doi: 10.3390/ijms18122589. Int J Mol Sci. 2017. PMID: 29194365 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical